InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: Whalatane post# 279130

Tuesday, 06/09/2020 2:59:20 PM

Tuesday, June 09, 2020 2:59:20 PM

Post# of 424195
KIWI...

I love your "Belle Indifferance"..

Did you read the two labels..The indications and usage are exactly the same. The Tier decision is not (as you and everyone else knows) going to be made by the PCPs its going to be made by the drug companies.

And all they care about is the cost..Look at the history of Vascepa vs Lovaza. How many tears on this board have been shed when Lovaza and gen Lovaza scripts were kicking Vascepa scripts to the curb.

It didn't make any difference and they stuck Vascepa at Tier 4 even when they knew about the R-I CVD results.And the wonderful fact V did not raise the LDL-C level,,.These drug companies are not in it for the love of fellow humans...They are "Business Men...

And keep in mind...The Generics are only supposed to be selling the drug for the ANCHOR indication..
My last three month cost for Vascepa was $580..dollars...The R-I study results are out and the Tier level is still Level 4...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News